FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Toshiro Kageshita

Research Profile

Disorders

Chemicals & Drugs

Procedures

Living Beings

Mouse

Anatomy

Physiology

Antibody Specificity

Co-author Network

Publications

TOP 3
Hiroshi Kato; Y Inoue; Tsuyoshi Ishihara; Toshiro Kageshita; Hironobu Ihn
Amelanotic malignant melanoma where primary lesion was discovered 5 years after metastasis in the lymph node.
Hazuki Nishi; Y Inoue; Toshiro Kageshita; Minoru Takata; Hironobu Ihn
The expression of human high molecular weight melanoma-associated antigen in acral lentiginous melanoma.
Masahiro Oka; Naoko Sumita; Masanobu Sakaguchi; Tetsushi Iwasaki; Toshinori Bito; Toshiro Kageshita; Ken-Ichi Sato; Yasuo Fukami; Chikako Nishigori
12-O-tetradecanoylphorbol-13-acetate inhibits melanoma growth by inactivation of STAT3 through protein kinase C-activated tyrosine phosphatase(s).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Toshiro Kageshita (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Hiroshi Kato; Y Inoue; Tsuyoshi Ishihara; Toshiro Kageshita; Hironobu Ihn
Amelanotic malignant melanoma where primary lesion was discovered 5 years after metastasis in the lymph node.
The Journal of dermatology 2010;37(8):730-4.
2010: Hazuki Nishi; Y Inoue; Toshiro Kageshita; Minoru Takata; Hironobu Ihn
The expression of human high molecular weight melanoma-associated antigen in acral lentiginous melanoma.
Bioscience trends 2010;4(2):86-9.
2009: Masahiro Oka; Naoko Sumita; Masanobu Sakaguchi; Tetsushi Iwasaki; Toshinori Bito; Toshiro Kageshita; Ken-Ichi Sato; Yasuo Fukami; Chikako Nishigori
12-O-tetradecanoylphorbol-13-acetate inhibits melanoma growth by inactivation of STAT3 through protein kinase C-activated tyrosine phosphatase(s).
The Journal of biological chemistry 2009;284(44):30416-23.
2009: Hazuki Kogushi-Nishi; Junko Kawasaki; Toshiro Kageshita; Tsuyoshi Ishihara; Hironobu Ihn
The prevalence of melanocytic nevi on the soles in the Japanese population.
Journal of the American Academy of Dermatology 2009;60(5):767-71.
2009: Satoshi Fukushima; Shinya Hirata; Yutaka Motomura; Daiki Fukuma; Yusuke Matsunaga; Yoshiaki Ikuta; Tokunori Ikeda; Toshiro Kageshita; Hironobu Ihn; Yasuharu Nishimura; Satoru Senju
Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(3):219-31.
2008: Kazuhiko Matsumoto; Hitomi Kubo; Hiroshi Murata; Hisashi Uhara; Minoru Takata; Shinichi Shibata; Satoshi Yasue; Akihiro Sakakibara; Yasushi Tomita; Toshiro Kageshita; Yutaka Kawakami; Masaaki Mizuno; Jun Yoshida; Toshiaki Saida
A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes.
Japanese journal of clinical oncology 2008;38(12):849-56.
2008: Jeffrey P North; Toshiro Kageshita; Daniel Pinkel; Philip E LeBoit; Boris C Bastian
Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma.
The Journal of investigative dermatology 2008;128(8):2024-30.
2008: Hitomi Kubo; Atsuko Ashida; Kazuhiko Matsumoto; Toshiro Kageshita; Akifumi Yamamoto; Toshiaki Saida
Interferon-beta therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells.
Archives of dermatological research 2008;300(6):297-301.
2008: Faith Chengetayi Muchemwa; Tetsuya Nakatsura; Satoshi Fukushima; Yasuharu Nishimura; Toshiro Kageshita; Hironobu Ihn
Differential expression of heat shock protein 105 in melanoma and melanocytic naevi.
Melanoma research 2008;18(3):166-71.
2008: Yuichiro Yoshino; Toshiro Kageshita; Motowo Nakajima; Minako Funakubo; Hironobu Ihn
Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma.
The Journal of dermatology 2008;35(4):206-14.
2008: F C Muchemwa; D Ma; Y Inoue; John A Curtin; Boris C Bastian; Hironobu Ihn; Toshiro Kageshita
Constitutive activation of the phosphatidyl inositol 3 kinase signalling pathway in acral lentiginous melanoma.
The British journal of dermatology 2008;158(2):411-3.
2007: Emiko Hayashi; Yuriko Matsuzaki; Go Hasegawa; Tomonori Yaguchi; Sachiko Kurihara; Tomonobu Fujita; Toshiro Kageshita; Makoto Sano; Yutaka Kawakami
Identification of a novel cancer-testis antigen CRT2 frequently expressed in various cancers using representational differential analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(21):6267-74.
2006: Satoshi Fukushima; Toshiro Kageshita; Shoji Wakasugi; Shigeto Matsushita; Atushi Kaguchi; Tsuyoshi Ishihara; Tomomichi Ono
Giant malignant peripheral nerve sheath tumor of the scalp.
The Journal of dermatology 2006;33(12):865-8.
2006: F C Muchemwa; Tetsuya Nakatsura; Hironobu Ihn; Toshiro Kageshita
Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma.
The British journal of dermatology 2006;155(3):582-5.
2006: Tsuyoshi Ishihara; Atsushi Kaguchi; Shigeto Matsushita; Shinya Shiraishi; Seiji Tomiguchi; Yasuyuki Yamashita; Toshiro Kageshita; Tomomichi Ono
Management of sentinel lymph nodes in malignant skin tumors using dynamic lymphoscintigraphy and the single-photon-emission computed tomography/computed tomography combined system.
International journal of clinical oncology 2006;11(3):214-20.
2006: W Luo; X Wang; Toshiro Kageshita; Shoji Wakasugi; Adam R Karpf; Soldano Ferrone
Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells.
Oncogene 2006;25(20):2873-84.
2006: Takashi Fukunaga; Hirofumi Soejima; Koichi Sugamura; Sunao Kojima; Seigo Sugiyama; Tomohiro Sakamoto; Michihiro Yoshimura; Toshihide Tanoue; Toshiro Kageshita; Tomomichi Ono; Hisao Ogawa
Acute myocardial infarction induced by cisplatin-based combination chemotherapy for malignant melanoma: a case report.
Journal of cardiology 2006;47(4):191-5.
2006: Kazumasa Wakamatsu; Akihiko Takasaki; Bertil Kågedal; Toshiro Kageshita; Shosuke Ito
Determination of eumelanin in human urine.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2006;19(2):163-9.
2006: Toshiro Kageshita; Kazuhiko Kuwahara; Masahiro Oka; Donglai Ma; Tomomichi Ono; Nobuo Sakaguchi
Increased expression of germinal center-associated nuclear protein (GANP) is associated with malignant transformation of melanocytes.
Journal of dermatological science 2006;42(1):55-63.
2006: Masahiro Oka; Chikako Nishigori; Toshiro Kageshita; Mei-Yu Hsu; Sunita Penmatcha; Meenhard Herlyn
Expression of PKC isoforms in human melanocytic cells in situ.
Journal of dermatological science 2006;41(2):157-61.
2006: Hidetomo Maruyoshi; Seigo Sugiyama; Satoshi Araki; Sunao Kojima; Takanori Hayasaki; Koichi Kaikita; Satoshi Fukushima; Toshiro Kageshita; Tomohiro Sakamoto; Michihiro Yoshimura; Tomomichi Ono; Hisao Ogawa
Floating coronary artery thrombus prior to the onset of acute myocardial infarction.
Internal medicine (Tokyo, Japan) 2006;45(3):173-4.
2005: Toshiaki Saida; Kazuhiko Matsumoto; Toshiro Kageshita; Masaaki Mizuno; Jun Yoshida
[Gene therapy for patients with malignant melanoma].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 12():566-71.
2005: John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-B Bröcker; Philip E LeBoit; Daniel Pinkel; Boris C Bastian
Distinct sets of genetic alterations in melanoma.
The New England journal of medicine 2005;353(20):2135-47.
2005: Yoshiaki Ikuta; Tetsuya Nakatsura; Toshiro Kageshita; Satoshi Fukushima; Shosuke Ito; Kazumasa Wakamatsu; Hideo Baba; Yasuharu Nishimura
Highly sensitive detection of melanoma at an early stage based on the increased serum secreted protein acidic and rich in cysteine and glypican-3 levels.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(22):8079-88.
2005: Yasuhiro Tamori; Xiaodong Tan; Kazuhiro Nakagawa; Eiji Takai; Junji Akagi; Toshiro Kageshita; Hiroshi Egami; Michio Ogawa
Clinical significance of MHC class II-associated invariant chain expression in human gastric carcinoma.
Oncology reports 2005;14(4):873-7.
2005: S Matsushita; Toshiro Kageshita; Tsuyoshi Ishihara
Comparison of dermoscopic and histopathological findings in a mucous melanoma of the lip.
The British journal of dermatology 2005;152(6):1324-6.
2005: Toshiro Kageshita; T Ishihara; Michael Campoli; Soldano Ferrone
Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Tissue antigens 2005;65(5):419-28.
2005: Xinhui Wang; Michael Campoli; Hyun Suk Cho; Takeshi Ogino; Nobuyuki Bandoh; Jijia Shen; Soo Young Hur; Toshiro Kageshita; Soldano Ferrone
A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.
Journal of immunological methods 2005;299(1-2):139-51.
2004: Motohiro Morioka; Jun-ichiro Hamada; Yuki Ohmori; Toshiro Kageshita; Yukitaka Ushio
Spinal arachnoid cyst containing nevus cells in a patient with a large congenital melanocytic nevus: case report.
Neurosurgery 2004;55(4):983-4.
2004: Tetsuya Nakatsura; Toshiro Kageshita; Shosuke Ito; Kazumasa Wakamatsu; Mikio Monji; Yoshiaki Ikuta; Satoru Senju; Tomomichi Ono; Yasuharu Nishimura
Identification of glypican-3 as a novel tumor marker for melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6612-21.
2004: Toshiaki Saida; Shigeo Kawachi; Minoru Takata; Hiroshi Kurita; Kenji Kurashina; Toshiro Kageshita; Morio Tonogi; Yuichiro Okazaki; Gen-yuki Yamane; Kaiyo Takubo; Yoshito Ueyama
Histopathological characteristics of malignant melanoma affecting mucous membranes: a unifying concept of histogenesis.
Pathology 2004;36(5):404-13.
2004: Mikio Monji; Tetsuya Nakatsura; Satoru Senju; Yoshihiro Yoshitake; Motohiro Sawatsubashi; Masanori Shinohara; Toshiro Kageshita; Tomomichi Ono; Akira Inokuchi; Yasuharu Nishimura
Identification of a novel human cancer/testis antigen, KM-HN-1, recognized by cellular and humoral immune responses.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6047-57.
2004: Michael Campoli; Chien-Chung Chang; Toshiro Kageshita; Xinhui Wang; James B McCarthy; Soldano Ferrone
Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance.
Critical reviews in immunology 2004;24(4):267-96.
2004: Mitsuomi Hirashima; Yumiko Kashio; Nozomu Nishi; Akira Yamauchi; Tada-atsu Imaizumi; Toshiro Kageshita; Naoki Saita; Takanori Nakamura
Galectin-9 in physiological and pathological conditions.
Glycoconjugate journal 2004;19(7-9):593-600.
2004: Shigeto Matsushita; Tsuyoshi Ishihara; Toshiro Kageshita; Kiyofumi Egawa; Taiga Miyake; Tomomichi Ono
Multiple squamous cell carcinomas arising in lesions of discoid lupus erythematosus.
The Journal of dermatology 2004;31(1):73-5.
2003: Janet L Maldonado; Jane Fridlyand; Hetal Patel; Ajay N Jain; Klaus J Busam; Toshiro Kageshita; Tomomichi Ono; Donna G Albertson; Daniel Pinkel; Boris C Bastian
Determinants of BRAF mutations in primary melanomas.
Journal of the National Cancer Institute 2003;95(24):1878-90.
2003: Tsuyoshi Ishihara; Toshiro Kageshita; Shigeto Matsushita; Tomomichi Ono
Investigation of sentinel lymph nodes of the axillary and cubital regions in upper-extremity malignant skin tumors: a series of 15 patients.
International journal of clinical oncology 2003;8(5):297-300.
2003: Xinhui Wang; B Liang; V Rebmann; J Lu; E Celis; Toshiro Kageshita; H Grosse-Wilde; Soldano Ferrone
Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2.
Tissue antigens 2003;62(2):139-48.
2003: Kazumasa Wakamatsu; Mika Yokochi; Akiko Naito; Toshiro Kageshita; Shosuke Ito
Comparison of phaeomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients.
Melanoma research 2003;13(4):357-63.
2003: Yasushi Ryuke; Masaaki Mizuno; Atsushi Natsume; Osamu Suzuki; Misato Nobayashi; Toshiro Kageshita; Kazuhiko Matsumoto; Toshiaki Saida; Jun Yoshida
Growth inhibition of subcutaneous mouse melanoma and induction of natural killer cells by liposome-mediated interferon-beta gene therapy.
Melanoma research 2003;13(4):349-56.
2003: Masahiro Oka; Toshiro Kageshita; Tomomichi Ono; Akinobu Goto; Toshio Kuroki; Masamitsu Ichihashi
Protein kinase C alpha associates with phospholipase D1 and enhances basal phospholipase D activity in a protein phosphorylation-independent manner in human melanoma cells.
The Journal of investigative dermatology 2003;121(1):69-76.
2003: Toshiro Kageshita; Tsuyoshi Ishihara; Hiroshi Tokuo; Yoko Funasaka; Masamitsu Ichihashi; J Dong; M Nakajima; Tomomichi Ono
Widespread expression of parathyroid hormone-related peptide in melanocytic cells.
The British journal of dermatology 2003;148(3):533-8.
2003: Toshiro Kageshita; Yuji Inoue; Tomomichi Ono
Spontaneous regression of congenital melanocytic nevi without evidence of the halo phenomenon.
Dermatology (Basel, Switzerland) 2003;207(2):193-5.
2003: Minoru Takata; Keishi Maruo; Toshiro Kageshita; Shibo Ikeda; Tomomichi Ono; Fumiaki Shirasaki; Kazuhiko Takehara; Boris C Bastian
Two cases of unusual acral melanocytic tumors: illustration of molecular cytogenetics as a diagnostic tool.
Human pathology 2003;34(1):89-92.
2002: Misato Nobayashi; Masaaki Mizuno; Toshiro Kageshita; Kazuhiko Matsumoto; Toshiaki Saida; Jun Yoshida
Repeated cationic multilamellar liposome-mediated gene transfer enhanced transduction efficiency against murine melanoma cell lines.
Journal of dermatological science 2002;29(3):206-13.
2002: Toshiro Kageshita; Yumiko Kashio; Akira Yamauchi; Masako Seki; Mohammad J Abedin; Nozomu Nishi; Hiroki Shoji; Takanori Nakamura; Tomomichi Ono; Mitsuomi Hirashima
Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance.
International journal of cancer. Journal international du cancer 2002;99(6):809-16.
2002: Toshiro Kageshita; Yoko Funasaka; Masamitsu Ichihashi; Tsuyoshi Ishihara; Hiroshi Tokuo; Tomomichi Ono
Differential expression of tissue factor and tissue factor pathway inhibitor in metastatic melanoma lesions.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2002;15(3):212-6.
2002: Hidetaka Katabuchi; R Honda; T Tajima; H Ohtake; Toshiro Kageshita; T Ono; Hitoshi Okamura
Clear cell sarcoma arising in the retroperitoneum.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2002;12(1):124-7.
2001: Shoji Wakasugi; Toshiro Kageshita; Tomomichi Ono
Metastatic melanoma to the palatine tonsil with a favourable prognosis.
The British journal of dermatology 2001;145(2):327-9.
2001: Toshiro Kageshita; CV Hamby; Tsuyoshi Ishihara; K Matsumoto; T Saida; Tomomichi Ono
Loss of beta-catenin expression associated with disease progression in malignant melanoma.
The British journal of dermatology 2001;145(2):210-6.
2001: Toshiro Kageshita; M Mizuno; Tomomichi Ono; K Matsumoto; T Saida; J Yoshida
Growth inhibition of human malignant melanoma transfected with the human interferon-beta gene by means of cationic liposomes.
Melanoma research 2001;11(4):337-42.
2001: Tsuyoshi Ishihara; A Nakamura; Toshiro Kageshita; Tomomichi Ono
Sentinel lymph nodes study in 30 cases of melanoma.
The Journal of dermatology 2001;28(7):347-52.
2001: Toshiro Kageshita; Yoko Funasaka; Masamitsu Ichihashi; Kazumasa Wakamatsu; Shosuke Ito; Tomomichi Ono
Tissue factor expression and serum level in patients with melanoma does not correlate with disease progression.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2001;14(3):195-200.
2001: Toshiro Kageshita; Y Kawakami; Tomomichi Ono
Clinical significance of MART-1 and HLA-A2 expression and CD8+ T cell infiltration in melanocytic lesions in HLA-A2 phenotype patients.
Journal of dermatological science 2001;25(1):36-44.
2000: Toshiro Kageshita; CV Hamby; S Hirai; T Kimura; Tomomichi Ono; Soldano Ferrone
Alpha(v)beta3 expression on blood vessels and melanoma cells in primary lesions: differential association with tumor progression and clinical prognosis.
Cancer immunology, immunotherapy : CII 2000;49(6):314-8.
2000: Toshiro Kageshita; CV Hamby; S Hirai; T Kimura; Tomomichi Ono; Soldano Ferrone
Differential clinical significance of alpha(v)Beta(3) expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes.
International journal of cancer. Journal international du cancer 2000;89(2):153-9.
2000: Toshiro Kageshita; N Kuribayashi; Tomomichi Ono
Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine.
The Journal of dermatology 2000;27(3):178-80.
1999: Toshiro Kageshita; A Yamamoto; N Yamazaki; K Ishihara; Tomomichi Ono
Low frequency of neutralizing antibodies against natural interferon-beta during adjuvant therapy for Japanese patients with melanoma.
Journal of dermatological science 1999;19(3):208-12.
1999: Toshiro Kageshita; S Hirai; Tomomichi Ono; D J Hicklin; S Ferrone
Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression.
The American journal of pathology 1999;154(3):745-54.
1999: Toshiro Kageshita; Tamano Matsui; S Hirai; Y Fukuda; Tomomichi Ono
Hypercalcaemia in melanoma patients associated with increased levels of parathyroid hormone-related protein.
Melanoma research 1999;9(1):69-73.
1999: Y Suenaga; Hidetaka Katabuchi; Hitoshi Okamura; Toshiro Kageshita; Tomomichi Ono
Increased serum levels of 5-S-cysteinyldopa and intercellular adhesion molecule-1 in a patient with a uterine amelanotic metastasis from a primary vaginal malignant melanoma.
Gynecologic oncology 1999;72(1):107-10.
1998: S Hirai; Y Shin; Toshiro Kageshita; M Syono; Y Maekawa; Tomomichi Ono
Clinical course of atopic dermatitis in Japanese patients.
Journal of dermatological science 1998;18(2):128-31.
1998: Tamano Matsui; Toshiro Kageshita; Tsuyoshi Ishihara; Seiji Tomiguchi; M Takahashi; Tomomichi Ono
Hypercalcemia in a patient with malignant melanoma arising in congenital giant pigmented nevus. A case of increased serum level of parathyroid hormone-related protein.
Dermatology (Basel, Switzerland) 1998;197(1):65-8.
1997: Toshiro Kageshita; Y Kawakami; S Hirai; Tomomichi Ono
Differential expression of MART-1 in primary and metastatic melanoma lesions.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(6):460-5.
1997: Toshiro Kageshita; Taeko K Naruse; S Hirai; T Ono; T Horikoshi; H Nakagawa; K Tamaki; K Hayashibe; M Ichihashi; J Nakayama; Y Hori; Akira Ozawa; Motomi Miyahara; Muneo Ohkido; Hidetoshi Inoko
Molecular genetic analysis of HLA class II alleles in Japanese patients with melanoma.
Tissue antigens 1997;49(5):466-70.
1997: S Hirai; Toshiro Kageshita; T Kimura; M Tsujisaki; K Imai; Kazumasa Wakamatsu; Shosuke Ito; Tomomichi Ono
Serum levels of sICAM-1 and 5-S-cysteinyldopa as markers of melanoma progression.
Melanoma research 1997;7(1):58-62.
1996: Toshiro Kageshita; T Naruse; S Hirai; T Horikoshi; H Nakagawa; K Tamaki; K Hayashibe; M Ichihashi; J Nakayama; Y Hori; A Ozawa; M Miyahara; M Ohkido; H Inoko; T Ono
HLA class I antigens in Japanese patients with melanoma.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(6):428-32.
1996: D J Hicklin; Toshiro Kageshita; Soldano Ferrone
Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing.
Tissue antigens 1996;48(1):38-46.
1995: Z Ye; Toshiro Kageshita; T Ishihara; S Ito; Tomomichi Ono
A case of malignant melanoma: disease progression correlated with serum levels of 5-S-Cysteinyldopa (5-S-CD) and intercellular adhesion molecule-1 (ICAM-1).
The Journal of dermatology 1995;22(5):370-5.
1995: Toshiro Kageshita; S Hirai; T Kimura; N Hanai; S Ohta; Tomomichi Ono
Association between sialyl Lewis(a) expression and tumor progression in melanoma.
Cancer research 1995;55(8):1748-51.
1995: Toshiro Kageshita; S Hirai; Tomomichi Ono; S Ferrone
Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic MAb MK2-23. Immunohistochemical analysis of the reactivity of anti-anti-idiotypic MAb with surgically removed melanoma lesions.
International journal of cancer. Journal international du cancer 1995;60(3):334-40.
1995: I Ikeda; Toshiro Kageshita; Tomomichi Ono
Multiple malignant melanoma and squamous-cell carcinoma in a burn scar.
Dermatology (Basel, Switzerland) 1995;191(4):328-32.
1995: A Yoshii; Toshiro Kageshita; H Tsushima; Tomomichi Ono
Clinical relevance of cathepsin B-like enzyme activity and cysteine proteinase inhibitor in melanocytic tumours.
Archives of dermatological research 1995;287(2):209-13.
1995: Toshiro Kageshita; A Yoshii; T Kimura; K Maruo; Tomomichi Ono; M Himeno; Y Nishimura
Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumours.
Archives of dermatological research 1995;287(3-4):266-72.
1994: Toshiro Kageshita; T Kimura; A Yoshi; S Hirai; Tomomichi Ono; S Ferrone
Antigenic profile of mucosal melanoma lesions.
International journal of cancer. Journal international du cancer 1994;56(3):370-4.
1994: Toshiro Kageshita; S Hirai; Tomomichi Ono
[Clinical trial of anti-idiotypic monoclonal antibodies in advanced melanoma].
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(2):163-9.
1993: Toshiro Kageshita; A Yoshii; T Kimura; N Kuriya; Tomomichi Ono; M Tsujisaki; K Imai; S Ferrone
Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma.
Cancer research 1993;53(20):4927-32.
1993: Soldano Ferrone; Toshiro Kageshita; S Hirai
Active specific immunotherapy of malignant melanoma with anti-idiotypic monoclonal antibodies.
The Journal of dermatology 1993;20(9):533-9.
1993: Toshiro Kageshita; Z Wang; L Calorini; A Yoshii; T Kimura; Tomomichi Ono; Sebastiano Gattoni-Celli; S Ferrone
Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.
Cancer research 1993;53(14):3349-54.
1993: H Yang; Z J Chen; Toshiro Kageshita; M Yamada; Soldano Ferrone
Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies.
European journal of immunology 1993;23(7):1671-7.
1993: Toshiro Kageshita; N Kuriya; Tomomichi Ono; T Horikoshi; M Takahashi; G Y Wong; S Ferrone
Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
Cancer research 1993;53(12):2830-3.
1993: Soldano Ferrone; Z J Chen; C C Liu; S Hirai; Toshiro Kageshita; A Mittelman
Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanoma.
Pharmacology & therapeutics 1993;57(2-3):259-90.
1992: Toshiro Kageshita; A Yoshii; T Kimura; Tomomichi Ono
Analysis of expression and soluble form of intercellular adhesion molecule-1 in malignant melanoma.
The Journal of dermatology 1992;19(11):836-40.
1992: Y Inaba; Kiyofumi Egawa; Toshiro Kageshita; Tomomichi Ono
Expression of CA 50 in normal human skin: comparative study of CEA and CA 19-9.
The Journal of dermatology 1992;19(10):592-7.
1992: Hideki Nakakuma; Kentaro Horikawa; Tatsuya Kawaguchi; M Hidaka; Shoichi Nagakura; S Hirai; Toshiro Kageshita; Tomomichi Ono; Tadashi Kagimoto; M Iwamori
Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
Japanese journal of clinical oncology 1992;22(5):308-12.
1992: Toshiro Kageshita; Tomomichi Ono; S Hirai; A Yoshii; T Kimura; Hideki Nakakuma; Kentaro Horikawa; Kiyoshi Takatsuki; S Ferrone
Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions.
Cancer research 1992;52(11):3201-7.
1991: Z J Chen; H Yang; Toshiro Kageshita; Soldano Ferrone
Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371.
Cancer research 1991;51(18):4790-7.
1991: Toshiro Kageshita; T Nakamura; M Yamada; N Kuriya; T Arao; S Ferrone
Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
Cancer research 1991;51(6):1726-32.
1991: S Hirai; Toshiro Kageshita; T Nakamura; A Yoshii; T Kimura; T Arao
[Expression of blood group-related antigens Lewis A, Lewis B, CA 19-9, and sialyl SSEA-1 in normal human skin in comparison with the patient's blood type].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology 1991;101(2):115-20.
1991: J Zhao; Kowasi Yoshioka; Teruhisa Miike; Toshiro Kageshita; T Arao
Nerve growth factor receptor immunoreactivity on the tunica adventitia of intramuscular blood vessels in childhood muscular dystrophies.
Neuromuscular disorders : NMD 1991;1(2):135-41.
1990: T Nakamura; Toshiro Kageshita; S Hirai; T Kimura; A Yoshii; Tomomichi Ono; T Arao
[Expression of HLA-class I and II antigens on basal cell carcinoma].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology 1990;100(14):1431-5.
1990: T Nakamura; Toshiro Kageshita; T Arao; N Yamazaki; K Ishihara
[Analysis of anti HMW.MAA antibodies in sera of melanoma patients using antiidiotypic monoclonal antibodies].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology 1990;100(11):1121-6.
1990: Toshiro Kageshita; T Nakamura; S Hirai; T Arao
[Expression of gangliosides on malignant melanoma].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology 1990;100(6):689-94.
1990: Toshiro Kageshita; T Nakamura; S Hirai; M Matsuno; Kiyofumi Egawa; T Arao
[Expression of nerve growth factor-receptor in normal skin and melanocytic tumor].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology 1990;100(2):169-73.
1990: T Nakamura; M Matsuno; Toshiro Kageshita; T Arao
[Expression of HLA-class II antigens in malignant melanoma].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology 1990;100(1):49-56.
1989: M Kusama; Toshiro Kageshita; Z J Chen; Soldano Ferrone
Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(11):3844-52.
1989: T Arao; M Yamada; W Matsunaga; Toshiro Kageshita; Tomomichi Ono
Proliferating giant pigmented nevus: a report of an unusual tumor occurring in association with a congenital giant pigmented nevus.
The Journal of investigative dermatology 1989;92(5 Suppl):315S-317S.
1989: M Temponi; Toshiro Kageshita; F Perosa; R Ono; H Okada; Soldano Ferrone
Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification.
Hybridoma 1989;8(1):85-95.
1989: F Perosa; Toshiro Kageshita; R Ono; Soldano Ferrone
Serological methods to detect anti-idiotypic antibodies.
Methods in enzymology 1989;178():74-90.
1987: M Kusama; Toshiro Kageshita; M Tsujisaki; F Perosa; Soldano Ferrone
Syngeneic antiidiotypic antisera to murine antihuman high-molecular-weight melanoma-associated antigen monoclonal antibodies.
Cancer research 1987;47(16):4312-7.